View Older Stories View More Recent Stories
-
Roth Capital Downgrades Martha Stewart Living Omnimedia (MSO) to Sell
-
Intellipharmaceutics (IPCI) Enters $5M Registered Direct Offering at $2.75/Share
-
Notable Analyst Rating Changes 03/07: (GOOG) (ESRX) (ANR) Upgraded; (P) (KFT) (ZLTQ) Downgraded
-
Roth Capital Starts Zions Bancorp (ZION) at Buy
-
Roth Capital Downgrades World Wrestling Entertainment (WWE) to Neutral
-
Roth Capital Starts Green Dot (GDOT) at Buy
-
Notable Analyst Rating Changes 03/05: (AIXG) (P) (LMT) Upgraded; (ZNGA) (CF) (PCS) Downgraded
-
Roth Capital Starts Perion Network (PERI) at Buy, $7.50 Price Target
-
Roth Capital Starts Stamps.com (STMP) at Buy
-
Roth Cuts U.S. Auto Parts Network (PRTS) to Neutral Following Q4 Report
-
Roth Capital Upgrades Giant Interactive (GA) to Buy
-
Uranium Resources (URRE) to Acquire Neutron Energy in All-Stock Deal
-
YM BioSciences (YMI) Closes 35M Offering at $2/Share
-
Roth Capital Adds OSI Systems (OSIS) to 'Focus List'
-
YM BioSciences (YMI) Prices 35M Offering at $2/Share
-
Roth Capital Downgrades China TransInfo Technology (CTFO) to Neutral
-
Roth Capital Starts InvenSense (INVN) at Buy
-
Roth Capital Starts Applied Minerals (AMNL) at Buy
-
Roth Capital Upgrades AsiaInfo-Linkage (ASIA) to Buy
-
Roth Capital Starts Ultra Clean (UCTT) at Buy
-
Roth Capital Downgrades Somaxon Pharma (SOMX) to Neutral
-
Roth Capital Downgrades Hollysys Automation Technologies (HOLI) to Neutral
-
Roth Capital Downgrades Planar Systems (PLNR) to Neutral
-
Roth Capital Upgrades Antares Pharma (AIS) to Buy
-
Roth Capital Starts HiSoft Technology International (HSFT) at Buy
-
Roth Capital Starts VanceInfo Technologies (VIT) at Buy
-
Roth Capital Starts iSoftStone Holdings (ISS) at Buy
-
Roth Capital Downgrades Wendy's (WEN) to Neutral
-
Roth Capital Starts Entropic (ENTR) at Buy
-
Roth Capital Upgrades Glacier Bancorp (GBCI) to Buy
-
Green Mountain Coffee (GMCR) volatility elevated at 89 into Q1
-
Roth Capital Downgrades Micromet (MITI) to Neutral
-
Roth Capital Upgrades Spectrum Pharmaceuticals (SPPI) to Buy
-
TVAX Biomedical (TVAX) Sees IPO Price of $9-$11/Share
-
Roth Capital Downgrades Regeneron Pharma (REGN) to Neutral
-
Roth Capital Upgrades Celldex Therapeutics (CLDX) to Buy
-
Synta (SNTA) Closes 7M Common Offering for Net Proceeds of ~$28.6M
-
Roth Capital Cuts WebMD (WBMD) to Neutral as Co. Ends Sale Talks, CEO Resigns
-
iBio (IBIO)Announces Common, Warrant Offering
-
Roth Capital Starts Crown Crafts (CRWS) at Buy
-
Roth Capital Starts Mindspeed Technologies (MSPD) at Buy
-
Chelsea Therapeutics (CHTP) Plans to Offer $20 Million in Common Stock
-
Notable Analyst Rating Changes 01/04: (LULU) (AKS) (XLS) Upgraded; (CLWR) (ALU) (MOS) Downgraded
-
Roth Capital Assumes Coverage on Cavium Networks (CAVM) at Buy
-
Roth Capital Starts Pericom Semiconductor (PSEM) at Buy
-
Roth Capital Starts PLX Technology (PLXT) at Buy
-
Roth Capital Starts Intel (INTC) at Neutral
-
Unusual 11 Midday Movers 12/29: (HOLI) (CRME) (IVAN) (AAU) Higher; (BLDP) (OPXT) (DECK) Lower
-
Notable Analyst Rating Changes 12/29: (HOLI) (NWSA) Upgraded; (UTX) Downgraded
-
Roth Capital Upgrades Hollysys Automation Technologies (HOLI) to Buy

